Á¢¼ö¹øÈ£ | ¿¬ÀÚ¸í | ¼Ò¼Ó | °ÀÇ ÀÏÁ¤ | °ÀÇ Á¦¸ñ |
---|---|---|---|---|
20220404090150 | ±è½ÅÇü |
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
IASP ICD-11 Update
|
20220409154016 | ÀÌ»óÀº |
ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Fibromyalgia Áø´Ü±âÁØ/°¡À̵å¶óÀÎ
|
20220413142136 | ±è»óÈÆ |
Á¶¼±´ëÇб³º´¿ø
|
¿¬¼ö±³À°(5¿ù 22ÀÏ) |
ÀÏ¹Ý ÁøÅëÁ¦ »ç¿ë ½Ã ÁÖÀÇÇÒ Á¡µé
|
20220413163331 | ÀÌÇö½Â |
Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ
|
¿¬¼ö±³À°(5¿ù 22ÀÏ) |
°ñ´Ù°øÁõ ó¹æ
|
20220418005841 | ±Ç´ë±Ù |
°æºÏ´ëÇб³ Ä¡°ú´ëÇÐ
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Orofacial pain and TMD(Temporomandibular Disorder)
|
20220418190822 | ½ÅÈ¿ë |
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ/...
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Introduction and Doctrinal Interpretation: Revised Public Notice about Nerve Block
|
20220418191549 | ½ÅÈ¿ë |
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ/...
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Case Review: Nerve Blocks and Other Pain Management
|
20220419104343 | ¼ÕÀºÈñ |
Ãæ³²´ëÇб³º´¿ø
|
¿¬¼ö±³À°(5¿ù 22ÀÏ) |
QST/QSART
|
20220419122803 | °Ã¶ÀÎ |
¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´...
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
COVID-19 ¹é½ÅÀÇ Overview
|
20220419144534 | ±è¿øÁß |
ÀÌÈÀÇ´ë
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Human Cells and Tissue in Pre-Clinical Studies: Human DRG
|
20220420133620 | º¯°æÁ¶ |
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ...
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Cancer pain for spine metastasis
|
20220420165551 | ¹ÚÁ¤Çö |
°¡Å縯´ëÇб³ ÀÎõ¼º¸ð...
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Useful Interventions for Headache Related Conditions
|
20220420173702 | ¹Ú¿µ¼® |
ÃæºÏ´ëÇб³º´¿ø
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Deep Brain Stimulation for pain
|
20220421083931 | ±è¿¬µ¿ |
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
Considerations when prescribing medications: Consideration regarding gabapentinoids
|
20220421121723 | ¹Ú»óÁØ |
¿¬¼¼ÀÇ´ë
|
Çмú´ëȸ(5¿ù 21ÀÏ) |
The First-Line Treatment for Cancer Related Neuropathic Pain in Global Guidelines; Value of Lyrica
|